8-K

Company

TScan Therapeutics, Inc.

Filed

November 1, 2024

Period of Report

October 28, 2024

Accession Number

0001193125-24-249124

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →